Arlington Mayor, Jim Ross to Welcome 2024 iC³®Attendees Thursday, October 3 - Friday, October 4 |
Mayor Jim Ross, City of Arlington |
BioNTX extends our heartfelt gratitude and appreciation to Mayor Jim Ross for agreeing to speak at iC³. Your insights and vision for the community truly inspire us all. We are deeply grateful for your time, effort, and dedication to North Texas life sciences and supporting the ecosystem as a whole. Your leadership and commitment to Arlington serves as a beacon for us all, and we are honored to have the privilege of hearing from you. |
New Companies Innovating Pain Therapies in North Texas |
Brian Meshkin Managing Partner, Profound Ventures |
Health Technology Executive and Award-Winning Social Entrepreneur of Profound Ventures, Brian Meshkin, has opened a CLIA-certified laboratory in the DFW area. Proove Genomics, supported by Outcomeus—the world's largest clinical-genetic databank for pain and orthopedics—aims to deliver personalized and predictive pain management solutions. Using advanced genetic and IT tools, Proove moves beyond subjective pain assessments to improve treatment outcomes. Meet Brian at the 2024 iC³ Summit! |
2024 EY Texas Report: Building Biotech in the Lone Star State |
Eva Hevron, Partner, Ernst & Young |
Erin Smith, JD, MPH, Director of Public-Private Partnerships, ARPA-H |
Cullum Clark, PhD, Director of Bush Institute, SMU Economic Growth Initiative |
For 35 years, EY's Beyond Borders Biotechnology Report has provided industry-leading analysis. More recently, as the focus has shifted to Texas, a burgeoning hub of biotech innovation, EY lends their expertise to tracking our growth. The upcoming 2024 EY Texas Report offers an in-depth look at the state's biotech landscape, revealing key statistics, trends, and market insights. Join us to explore the current state and future of biotech in Texas, as EY returns with their Texas edition of the Global Beyond Borders Report. Join as renowned speakers share their perspectives on the challenges and opportunities facing Texas, the 8th largest economy in the world. EY Texas Report to be Presented at the iC³ Summit October 3rd & 4th Read the Latest EY Beyond Borders Report Below! |
The iC³ Tech Transfer Showcase: For the NEXT BIG Idea Applications due on Monday, August 12, 2024 |
The Tech Transfer Showcase at the iC³ Life Science Summit is the premier opportunity to present innovative intellectual property to a select audience of industry professionals, leaders, and investors; offering an opportunity for potential collaborations, funding, guidance, and networking, Submission Guidelines - Application deadline August 12, 2024 at 11:59 pm CST - Open to all university technology transfer offices in Texas - Two submissions per university campus - Applications will be reviewed by a panel of industry experts - Winning applicants will be paired with an industry mentor to help craft and polish your presentation |
The 2024 Tech Transfer Showcase Will Award a Cash Prize! |
Get Ready! iC³ Summit Partnering App Coming Soon |
Class of 2024 iC³ Rising Stars Emerge |
Congratulations Single Cell Biotechnology & Almaden Genomics! BioNTX is proud to continue growing a legacy of showcasing innovative companies at the iC³ Life Science Summit and invites you to nominate a Rising Star— an exceptional Texas company with no more than $100 million in funding or revenue, solving critical challenges in health, pharma, or biosciences. Rising Stars are change-makers and innovators recognized for remarkable achievements, groundbreaking technologies, products, and dedication to addressing the world's most daunting social and healthcare issues. |
2030: The Future of Cell & Gene Therapy in Texas |
Adora Ndu, PharmD, JD, Chief Regulatory Affairs Officer, BridgeBio |
Steven Gray, PhD, Director of Translational Gene Therapy, UT Southwestern Medical Center |
Explore the key trends and pressing issues in cell and gene therapy today, with a focus on the readiness of Texas to support research and development in this transformative field. Gain insights into the latest scientific advancements, regulatory challenges, and infrastructure needs. What are Texas' current capabilities? What strategic initiatives are being developed to position the state as a leader in cell and gene therapy innovation? |
Overcoming Obstacles: Fundraising in Current Financial Climates |
Timothy Morris, Founder & Managing Member, Accolade Pharma |
John Pennett, Partner, EisnerAmper |
Chris Garabedian, CEO, Xontogeny,
Portfolio Manager | Perceptive Advisor |
Engage with industry experts as they characterize the current biotech financing environment, explore best-practices for overcoming fundraising obstacles in difficult financial climates, and how markets and investors can be leveraged successfully to advance your innovation. Learn vital strategies for identifying and reaching high-probability investors, crafting compelling pitches, and structuring intelligent milestones in early-stages. Leave with actionable insights for securing investments and building investor confidence in a challenging environment. |
Ensuring Quality & Efficiency in Biomanufacturing Logistics |
Frank Van Gelder, Secretary General, Pharma. Aero |
Roel Gevaers, Professor of Logistics, University of Antwerp |
Learn about the latest trends and critical issues in biomanufacturing and the logistics of transporting biologics and pharmaceuticals. Gain insights into the advancements in biotechnology, the complexities of maintaining product integrity during transport, and the crucial role of logistics hubs like DFW Airport. |
iC³ Sponsor Spotlight: EisnerAmper |
EisnerAmper is the solution to complex, long-term and short-term financial and accounting services. Their focus on Accountability, Responsiveness, Relationship-oriented interactions, and highly principled work ethics makes them adaptive for all types of enterprises. |
iC³ Sponsor Spotlight: CRB |
CRB is a leading provider of sustainable engineering, architecture, construction, and consulting solutions to the global life sciences and food & beverage industries. With a rich 40-year history, CRB is a privately held company dedicated to delivering world-class solutions that drive success and positive change for clients, employees, and communities. |
Celebrating a Decade of Innovation and Excellence in North Texas |
Experience the 10th Annual iC³ Life Science & Healthcare Innovation Summit at Loews Arlington Convention Center! October 3rd & 4th, join more than 1000 attendees from around the globe for a transformative event as the leaders, visionaries, and minds in North Texas, the Lone Star State, the United States, and the world, converge in a vibrant platform for bioscience and healthcare innovation. Engage in thought-provoking discussion, share ground-breaking research and best-practices, explore industry trends, and delve into emerging technologies shaping the future of healthcare and biomedicine. |
iC³ Summit Early-Bird Discounts & Extra Savings! |
Register now for the iC³ Life Science Summit to take advantage of early bird ticket discounts and get exclusive savings! Secure tickets early and enjoy special 10th Anniversary iC³ pricing! BioNTX members receive additional discounts on early bird rates, making this the perfect time to register and save! |
Thank You for Your Support! |
|
